297 related articles for article (PubMed ID: 8156931)
21. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
[TBL] [Abstract][Full Text] [Related]
22. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
Sato M; Zeng GQ; Rowley E; Turner CH
Endocrinology; 1998 Nov; 139(11):4642-51. PubMed ID: 9794476
[TBL] [Abstract][Full Text] [Related]
23. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
Kidder LS; Schmidt IU; Evans GL; Turner RT
Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of skeletal response to estrogen depletion at red and yellow marrow sites in rats.
Li M; Shen Y; Qi H; Wronski TJ
Anat Rec; 1996 Jul; 245(3):472-80. PubMed ID: 8800405
[TBL] [Abstract][Full Text] [Related]
25. Dose-response effects of 2-methoxyestradiol on estrogen target tissues in the ovariectomized rat.
Sibonga JD; Lotinun S; Evans GL; Pribluda VS; Green SJ; Turner RT
Endocrinology; 2003 Mar; 144(3):785-92. PubMed ID: 12586754
[TBL] [Abstract][Full Text] [Related]
26. Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene.
Turner RT; Evans GL; Sluka JP; Adrian MD; Bryant HU; Turner CH; Sato M
Endocrinology; 1998 Sep; 139(9):3712-20. PubMed ID: 9724022
[TBL] [Abstract][Full Text] [Related]
27. Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status.
Moon LY; Wakley GK; Turner RT
Endocrinology; 1991 Sep; 129(3):1568-74. PubMed ID: 1874188
[TBL] [Abstract][Full Text] [Related]
28. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
[TBL] [Abstract][Full Text] [Related]
29. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
[TBL] [Abstract][Full Text] [Related]
30. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats.
Erben RG; Bromm S; Stangassinger M
Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082
[TBL] [Abstract][Full Text] [Related]
31. Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat.
Martel C; Picard S; Richard V; BĂ©langer A; Labrie C; Labrie F
J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):45-56. PubMed ID: 11074355
[TBL] [Abstract][Full Text] [Related]
32. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Fanti P; Monier-Faugere MC; Geng Z; Schmidt J; Morris PE; Cohen D; Malluche HH
Osteoporos Int; 1998; 8(3):274-81. PubMed ID: 9797913
[TBL] [Abstract][Full Text] [Related]
33. Influence of aging on cortical and trabecular bone response to estradiol treatment in ovariectomized rats.
Gaumet N; Braillon P; Seibel MJ; Pointillart A; Coxam V; Davicco MJ
Gerontology; 1998; 44(3):132-9. PubMed ID: 9592683
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
Grese TA; Cho S; Finley DR; Godfrey AG; Jones CD; Lugar CW; Martin MJ; Matsumoto K; Pennington LD; Winter MA; Adrian MD; Cole HW; Magee DE; Phillips DL; Rowley ER; Short LL; Glasebrook AL; Bryant HU
J Med Chem; 1997 Jan; 40(2):146-67. PubMed ID: 9003514
[TBL] [Abstract][Full Text] [Related]
35. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.
Turner RT; Evans GL; Cavolina JM; Halloran B; Morey-Holton E
Endocrinology; 1998 Oct; 139(10):4086-91. PubMed ID: 9751486
[TBL] [Abstract][Full Text] [Related]
36. Lack of an effect of sodium zeolite A on rat tibia histomorphometry.
Firling CE; Evans GL; Wakley GK; Sibonga J; Turner RT
J Bone Miner Res; 1996 Feb; 11(2):254-63. PubMed ID: 8822350
[TBL] [Abstract][Full Text] [Related]
37. Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.
Komm BS; Vlasseros F; Samadfam R; Chouinard L; Smith SY
Bone; 2011 Sep; 49(3):376-86. PubMed ID: 21658483
[TBL] [Abstract][Full Text] [Related]
38. The catechol estrogen, 4-hydroxyestrone, has tissue-specific estrogen actions.
Westerlind KC; Gibson KJ; Evans GL; Turner RT
J Endocrinol; 2000 Nov; 167(2):281-7. PubMed ID: 11054642
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice.
Onoe Y; Miyaura C; Ito M; Ohta H; Nozawa S; Suda T
J Bone Miner Res; 2000 Mar; 15(3):541-9. PubMed ID: 10750569
[TBL] [Abstract][Full Text] [Related]
40. Evidence that ibuprofen antagonizes selective actions of estrogen and tamoxifen on rat bone.
Sibonga JD; Bell NH; Turner RT
J Bone Miner Res; 1998 May; 13(5):863-70. PubMed ID: 9610751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]